Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Journal of clinical oncology

Results: 1-25/275

Authors: SIKIC BI
Citation: Bi. Sikic, MODULATION OF MULTIDRUG-RESISTANCE - AT THE THRESHOLD, Journal of clinical oncology, 11(9), 1993, pp. 1629-1635

Authors: HURD DD
Citation: Dd. Hurd, POSTREMISSION THERAPY FOR THE YOUNGER ADULT PATIENT WITH ACUTE MYELOGENOUS LEUKEMIA - DEFINING A ROLE FOR TRANSPLANTATION, Journal of clinical oncology, 11(9), 1993, pp. 1636-1638

Authors: FREI E FREIREICH EJ
Citation: E. Frei et Ej. Freireich, THE CLINICAL CANCER RESEARCHER - STILL AN EMBATTLED SPECIES, Journal of clinical oncology, 11(9), 1993, pp. 1639-1651

Authors: LIST AF SPIER C GREER J WOLFF S HUTTER J DORR R SALMON S FUTSCHER B BAIER M DALTON W
Citation: Af. List et al., PHASE-I II TRIAL OF CYCLOSPORINE AS A CHEMOTHERAPY-RESISTANCE MODIFIER IN ACUTE-LEUKEMIA/, Journal of clinical oncology, 11(9), 1993, pp. 1652-1660

Authors: SANZ MA DELARUBIA J SANZ GF MARTIN G MARTINEZ J JARQUE I SEMPERE A GOMIS F SENENT L SOLER MA LOPEZ F ARILLA MJ CARPIO N GUINOT M PALAU J TUDELA M MARTY ML
Citation: Ma. Sanz et al., BUSULFAN PLUS CYCLOPHOSPHAMIDE FOLLOWED BY AUTOLOGOUS BLOOD STEM-CELLTRANSPLANTATION FOR PATIENTS WITH ACUTE MYELOBLASTIC-LEUKEMIA IN 1ST COMPLETE REMISSION - A REPORT FROM A SINGLE INSTITUTION, Journal of clinical oncology, 11(9), 1993, pp. 1661-1667

Authors: FINKE J SLANINA J LANGE W DOLKEN G
Citation: J. Finke et al., PERSISTENCE OF CIRCULATING T(14-18)-POSITIVE CELLS IN LONG-TERM REMISSION AFTER RADIATION-THERAPY FOR LOCALIZED-STAGE FOLLICULAR LYMPHOMA, Journal of clinical oncology, 11(9), 1993, pp. 1668-1673

Authors: CARBONE A TIRELLI U GLOGHINI A VOLPE R BOIOCCHI M
Citation: A. Carbone et al., HUMAN-IMMUNODEFICIENCY-VIRUS ASSOCIATED SYSTEMIC LYMPHOMAS MAY BE SUBDIVIDED INTO 2 MAIN GROUPS ACCORDING TO EPSTEIN-BARR VIRAL LATENT GENE-EXPRESSION, Journal of clinical oncology, 11(9), 1993, pp. 1674-1681

Authors: HESKETH P CAGUIOA P KOH H DEWEY H FACADA A MCCAFFREY R PARKER K NYLEN P WOODWORTH T
Citation: P. Hesketh et al., CLINICAL ACTIVITY OF A CYTOTOXIC FUSION PROTEIN IN THE TREATMENT OF CUTANEOUS T-CELL LYMPHOMA, Journal of clinical oncology, 11(9), 1993, pp. 1682-1690

Authors: REMICK SC MCSHARRY JJ WOLF BC BLANCHARD CG EASTMAN AY WAGNER H PORTUESE E WIGHTON T POWELL D PEARCE T HORTON J RUCKDESCHEL JC
Citation: Sc. Remick et al., NOVEL ORAL COMBINATION CHEMOTHERAPY IN THE TREATMENT OF INTERMEDIATE-GRADE AND HIGH-GRADE AIDS-RELATED NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 11(9), 1993, pp. 1691-1702

Authors: BOKEMEYER C SCHMOLL HJ
Citation: C. Bokemeyer et Hj. Schmoll, SECONDARY NEOPLASMS FOLLOWING TREATMENT OF MALIGNANT GERM-CELL TUMORS, Journal of clinical oncology, 11(9), 1993, pp. 1703-1709

Authors: RIVKIN SE GREEN S METCH B JEWELL WR COSTANZI JJ ALTMAN SJ MINTON JP OBRYAN RM OSBORNE CK
Citation: Se. Rivkin et al., ONE VERSUS 2 YEARS OF CMFVP ADJUVANT CHEMOTHERAPY IN AXILLARY NODE-POSITIVE AND ESTROGEN-RECEPTOR NEGATIVE PATIENTS - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 11(9), 1993, pp. 1710-1716

Authors: STAL O DUFMATS M HATSCHEK T CARSTENSEN J KLINTENBERG C RUTQVIST LE SKOOG L SULLIVAN S WINGREN S NORDENSKJOLD B
Citation: O. Stal et al., S-PHASE FRACTION IS A PROGNOSTIC FACTOR IN STAGE-I BREAST-CARCINOMA, Journal of clinical oncology, 11(9), 1993, pp. 1717-1722

Authors: PARIDAENS R HEUSON JC JULIEN JP VEYRET C VANZYL J KLIJN JGM SYLVESTER R MIGNOLET F
Citation: R. Paridaens et al., ASSESSMENT OF ESTROGENIC RECRUITMENT BEFORE CHEMOTHERAPY IN ADVANCED BREAST-CANCER - A DOUBLE-BLIND RANDOMIZED STUDY, Journal of clinical oncology, 11(9), 1993, pp. 1723-1728

Authors: BEARMAN SI ANDERSON GL MORI M HINDS MS SHULMAN HM MCDONALD GB
Citation: Si. Bearman et al., VENOOCCLUSIVE DISEASE OF THE LIVER - DEVELOPMENT OF A MODEL FOR PREDICTING FATAL OUTCOME AFTER MARROW TRANSPLANTATION, Journal of clinical oncology, 11(9), 1993, pp. 1729-1736

Authors: GREM JL JORDAN E ROBSON ME BINDER RA HAMILTON JM STEINBERG SM ARBUCK SG BEVERIDGE RA KALES AN MILLER JA WEISS RB MCATEE N CHEN A GOLDSPIEL B SOVER E ALLEGRA CJ
Citation: Jl. Grem et al., PHASE-II STUDY OF FLUOROURACIL, LEUCOVORIN, AND INTERFERON ALFA-2A INMETASTATIC COLORECTAL-CARCINOMA, Journal of clinical oncology, 11(9), 1993, pp. 1737-1745

Authors: BLACK KL CIACCI JD AMMIRATI M SELCH MT BECKER DP
Citation: Kl. Black et al., CLINICAL-TRIAL OF SERRATIA-MARCESCENS EXTRACT AND RADIATION-THERAPY IN PATIENTS WITH MALIGNANT ASTROCYTOMA, Journal of clinical oncology, 11(9), 1993, pp. 1746-1750

Authors: MORTON DL WEN DR FOSHAG LJ ESSNER R COCHRAN A
Citation: Dl. Morton et al., INTRAOPERATIVE LYMPHATIC MAPPING AND SELECTIVE CERVICAL LYMPHADENECTOMY FOR EARLY-STAGE MELANOMAS OF THE HEAD AND NECK, Journal of clinical oncology, 11(9), 1993, pp. 1751-1756

Authors: PISTERS KMW KRIS MG GRALLA RJ ZAMAN MB HEELAN RT MARTINI N
Citation: Kmw. Pisters et al., PATHOLOGICAL COMPLETE RESPONSE IN ADVANCED NON-SMALL-CELL LUNG-CANCERFOLLOWING PREOPERATIVE CHEMOTHERAPY - IMPLICATIONS FOR THE DESIGN OF FUTURE NON-SMALL-CELL LUNG-CANCER COMBINED-MODALITY TRIALS, Journal of clinical oncology, 11(9), 1993, pp. 1757-1762

Authors: PICCI P ROUGRAFF BT BACCI G NEFF JR SANGIORGI L CAZZOLA A BALDINI N FERRARI S MERCURI M RUGGIERI P CALDORA P BENASSI MS FABBRI N MONTI C CAMPANACCI M
Citation: P. Picci et al., PROGNOSTIC-SIGNIFICANCE OF HISTOPATHOLOGIC RESPONSE TO CHEMOTHERAPY IN NONMETASTATIC EWINGS-SARCOMA OF THE EXTREMITIES, Journal of clinical oncology, 11(9), 1993, pp. 1763-1769

Authors: GARAVENTA A DEBERNARDI B PIANCA C DONFRANCESCO A DIMONTEZEMOLO LC DITULLIO MT BAGNULO S MANCINI A CARLI M PESSION A ARRIGHINI A DICATALDO A TAMARO P IASONNI V TACCONE A ROGERS D BONI L
Citation: A. Garaventa et al., LOCALIZED BUT UNRESECTABLE NEUROBLASTOMA - TREATMENT AND OUTCOME OF 145 CASES, Journal of clinical oncology, 11(9), 1993, pp. 1770-1779

Authors: ASSELIN BL WHITIN JC COPPOLA DJ RUPP IP SALLAN SE COHEN HJ
Citation: Bl. Asselin et al., COMPARATIVE PHARMACOKINETIC STUDIES OF 3 ASPARAGINASE PREPARATIONS, Journal of clinical oncology, 11(9), 1993, pp. 1780-1786

Authors: ROBINS HI COHEN JD SCHMITT CL TUTSCH KD FEIERABEND C ARZOOMANIAN RZ ALBERTI D DOLEIRE F LONGO W HEISS C RUSHING D LOVE R SPRIGGS D
Citation: Hi. Robins et al., PHASE-I CLINICAL-TRIAL OF CARBOPLATIN AND 41.8-DEGREES-C WHOLE-BODY HYPERTHERMIA IN CANCER-PATIENTS, Journal of clinical oncology, 11(9), 1993, pp. 1787-1794

Authors: SAVARESE DMF DENICOFF AM BERG SL HILLIG M BAKER SP OSHAUGHNESSY JA CHOW C OTTERSON GA BALIS FM POPLACK DG COWAN KH
Citation: Dmf. Savarese et al., PHASE-I STUDY OF HIGH-DOSE PIROXANTRONE WITH GRANULOCYTE-COLONY-STIMULATING FACTOR, Journal of clinical oncology, 11(9), 1993, pp. 1795-1803

Authors: DERIESE WTW CRABTREE WN ALLHOFF EP WERNER M LIEDKE S LENIS G ATZPODIEN J KIRCHNER H
Citation: Wtw. Deriese et al., PROGNOSTIC-SIGNIFICANCE OF KI-67 IMMUNOSTAINING IN NONMETASTATIC RENAL-CELL CARCINOMA, Journal of clinical oncology, 11(9), 1993, pp. 1804-1808

Authors: VOGELZANG NJ LIPTON A FIGLIN RA
Citation: Nj. Vogelzang et al., SUBCUTANEOUS INTERLEUKIN-2 PLUS INTERFERON ALFA-2A IN METASTATIC RENAL-CANCER - AN OUTPATIENT MULTICENTER TRIAL, Journal of clinical oncology, 11(9), 1993, pp. 1809-1816
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>